Meridian Co. Ltd.-Appoints a New President for Belgium Medical Inc
6/3/2004
Meridian Co. Ltd.-Appoints a New President for Meridian
Medical Inc. VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Jun 3, 2004) - Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB: MRDAF), is pleased to announce that its wholly owned subsidiary Meridian Medical Inc. ("MMI") has hired Mrs. Debbie Williams as President of MMI. Mrs. Williams will be instrumental in the sale of Meridian's products throughout North America. Her medical expertise, relationships with medical professionals and distributors, strong sales background and enthusiasm will be an incredible asset to Meridian. Debbie Williams has over 25 years of experience as a Clinical Research Associate and Registered Nurse working for companies such as PPD Development and Omnicare Clinical Research. Mrs. Williams also has a strong background in sales. She was the Director of Sales for Western Canada for Lifestart Learning Systems, where she established a strong market base, assisted with the development of pre-natal educational products, hired and trained nurse educators, and researched and wrote articles for Lifestart. Her management skills were enhanced by a senior management position in a Phase I pharmaceutical research unit located at Vancouver Hospital. The Company feels very fortunate to have Mrs. Williams onboard. She was enjoying an extremely successful career as a Research Associate, working in conjunction with high profile pharmaceutical companies, but felt she wanted to contribute more by combining her medical expertise with her sales and marketing experience in both public and private companies. Mrs. Williams understands the importance of creating a superior company that will ultimately increase shareholder value. Working for Meridian is the perfect opportunity to combine these skills while being given the opportunity to work with a company that spreads the message of prevention and education. "I am thrilled to be appointed President to lead Meridian at such an exciting point in its evolution. We will be focusing on building and expanding our sales and marketing program to capitalize upon the growth of the wellness industry. Meridian anticipates a prominent presence in both conventional and complimentary medicine", states Debbie Williams. "I can't think of a better opportunity to contribute to the prevention of disease, which is the mission of Meridian. I believe the vision of Meridian closely mirrors the vision of one of our great ancestors, Thomas A. Edison, "The doctor of the future will give no medicine, but will interest his patients in the care of the human frame, in diet, and in the cause and prevention of disease." Meridian has a solid line of products with a large target market, but due to the overwhelming product interest in North America, the Company will initially launch its sales campaign with the Digital Pulse Analyzer ("DPA"). The DPA measures the elasticity of small and large arteries and determines if patients have symptoms of the early stages of cardiovascular disease that requires further diagnosis and treatment. The FDA approved test is inexpensive, non-invasive, and can provide results in one minute. The DPA can detect disease that has the potential for a heart attack and stroke, and can be used to monitor a patient's recovery through treatments such as diet, exercise or medication. According to the American Heart Association, in 1999 cardiovascular disease contributed to a third of global deaths. Meridian's mission is to see these statistics reduced through the use of its preventative diagnostic devices. The global market for preventative therapies stands at approximately US$60 billion a year and is steadily growing. Prevention not only saves lives and allows patients to be proactive in their health care, but it will be a necessity to reduce the growing costs and burdens placed on our health care system. About Meridian Meridian is an established leader in the research, development, manufacturing and sales of integrative medical devices successfully marketed to a wide variety of health care practitioners worldwide. The products have FDA and other recognized regulatory approvals as well as 18 registered patents on its technology. The Company is committed to the ongoing clinical research for the globalization and advancement of integrative medical products that contribute to the better health of humanity. -30- FOR FURTHER INFORMATION PLEASE CONTACT: Meridian Co., Ltd. Craig Auringer 1-866-802-1222 Website (Korean): www.meridian.co.kr Website (North America): meridianmedical.ca
|